234 related articles for article (PubMed ID: 31825647)
21. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
22. Interventions targeted at women to encourage the uptake of cervical screening.
Staley H; Shiraz A; Shreeve N; Bryant A; Martin-Hirsch PP; Gajjar K
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD002834. PubMed ID: 34694000
[TBL] [Abstract][Full Text] [Related]
23. A pragmatic randomized clinical trial of multilevel interventions to improve adherence to lung cancer screening (The Larch Study): Study protocol.
Luce C; Palazzo L; Anderson ML; Carter-Bawa L; Gao H; Green BB; Ralston JD; Rogers K; Su YR; Tuzzio L; Triplette M; Wernli KJ
Contemp Clin Trials; 2024 May; 140():107495. PubMed ID: 38467273
[TBL] [Abstract][Full Text] [Related]
24. Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk.
Crosbie PA; Gabe R; Simmonds I; Kennedy M; Rogerson S; Ahmed N; Baldwin DR; Booton R; Cochrane A; Darby M; Franks K; Hinde S; Janes SM; Macleod U; Messenger M; Moller H; Murray RL; Neal RD; Quaife SL; Sculpher M; Tharmanathan P; Torgerson D; Callister ME
BMJ Open; 2020 Sep; 10(9):e037075. PubMed ID: 32912947
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.
Jaine R; Kvizhinadze G; Nair N; Blakely T
Lung Cancer; 2018 Oct; 124():233-240. PubMed ID: 30268467
[TBL] [Abstract][Full Text] [Related]
26. Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.
Spiro SG; Shah PL; Rintoul RC; George J; Janes S; Callister M; Novelli M; Shaw P; Kocjan G; Griffiths C; Falzon M; Booton R; Magee N; Peake M; Dhillon P; Sridharan K; Nicholson AG; Padley S; Taylor MN; Ahmed A; Allen J; Ngai Y; Chinyanganya N; Ashford-Turner V; Lewis S; Oukrif D; Rabbitts P; Counsell N; Hackshaw A
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31537697
[TBL] [Abstract][Full Text] [Related]
27. New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.
Li J; Chung S; Wei EK; Luft HS
BMC Health Serv Res; 2018 Jul; 18(1):525. PubMed ID: 29976189
[TBL] [Abstract][Full Text] [Related]
28. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
[TBL] [Abstract][Full Text] [Related]
29. Implementation of a Lung Cancer Screening Program in Two Federally Qualified Health Centers.
Watson L; Cotter MM; Shafer S; Neloms K; Smith RA; Sharpe K
Public Health Rep; 2021; 136(4):397-402. PubMed ID: 33440129
[TBL] [Abstract][Full Text] [Related]
30. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
[TBL] [Abstract][Full Text] [Related]
31. Low-Dose Computed Tomography (LDCT) Lung Cancer Screening in Asian Female Never-Smokers Is as Efficacious in Detecting Lung Cancer as in Asian Male Ever-Smokers: A Systematic Review and Meta-Analysis.
Triphuridet N; Zhang SS; Nagasaka M; Gao Y; Zhao JJ; Syn NL; Hanaoka T; Ou SI; Shum E
J Thorac Oncol; 2023 Jun; 18(6):698-717. PubMed ID: 36775191
[TBL] [Abstract][Full Text] [Related]
32. Mapping the spectrum of psychological and behavioural responses to low-dose CT lung cancer screening offered within a Lung Health Check.
Kummer S; Waller J; Ruparel M; Cass J; Janes SM; Quaife SL
Health Expect; 2020 Apr; 23(2):433-441. PubMed ID: 31961060
[TBL] [Abstract][Full Text] [Related]
33. Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis.
Lam ACL; Aggarwal R; Cheung S; Stewart EL; Darling G; Lam S; Xu W; Liu G; Kavanagh J
Lung Cancer; 2020 Aug; 146():134-144. PubMed ID: 32535225
[TBL] [Abstract][Full Text] [Related]
34. Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants.
Pastorino U; Boffi R; Marchianò A; Sestini S; Munarini E; Calareso G; Boeri M; Pelosi G; Sozzi G; Silva M; Sverzellati N; Galeone C; La Vecchia C; Ghirardi A; Corrao G
J Thorac Oncol; 2016 May; 11(5):693-699. PubMed ID: 26921675
[TBL] [Abstract][Full Text] [Related]
35. Incidence of Head and Neck Cancer With Lung Cancer Screening: Secondary Analysis of a Randomized Controlled Trial.
Jassal JS; Grauer JS; Cramer JD
Laryngoscope; 2022 Aug; 132(8):1609-1614. PubMed ID: 34984679
[TBL] [Abstract][Full Text] [Related]
36. Lung cancer risk by years since quitting in 30+ pack year smokers.
Pinsky PF; Zhu CS; Kramer BS
J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of cardiovascular risk in a lung cancer screening cohort.
Ruparel M; Quaife SL; Dickson JL; Horst C; Burke S; Taylor M; Ahmed A; Shaw P; Soo MJ; Nair A; Devaraj A; O'Dowd EL; Bhowmik A; Navani N; Sennett K; Duffy SW; Baldwin DR; Sofat R; Patel RS; Hingorani A; Janes SM
Thorax; 2019 Dec; 74(12):1140-1146. PubMed ID: 31558626
[TBL] [Abstract][Full Text] [Related]
38. Capitalizing on a teachable moment: Development of a targeted self-help smoking cessation intervention for patients receiving lung cancer screening.
Meltzer LR; Unrod M; Simmons VN; Brandon KO; Piñeiro B; Palmer AM; Brandon TH
Lung Cancer; 2019 Apr; 130():121-127. PubMed ID: 30885332
[TBL] [Abstract][Full Text] [Related]
39. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
